Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TENET HEALTHCARE CORPTHC · Entity 2563 | Director · CEO | August 24, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TENET HEALTHCARE CORP
Report date August 24, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 433,564 |
Ending reported balance
After 2026-08-25 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-08-24 · Sale · Disposed 13,344 · Balance 520,220 F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57. F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Row 2 · 2026-08-24 · Sale · Disposed 36,656 · Balance 483,564 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14. Row 3 · 2026-08-25 · Sale · Disposed 17,220 · Balance 466,344 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64. Row 4 · 2026-08-25 · Sale · Disposed 24,881 · Balance 441,463 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F5: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64. Row 5 · 2026-08-25 · Sale · Disposed 7,899 · Balance 433,564 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F6: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55. |
Filing footnotes · ownership attribution and instrument terms
F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57.
F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14.
F4: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64.
F5: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64.
F6: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2024 Filed Feb 28, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 57,452 | $92.80 | $5,331,545.60 |
DisclosureSEC source: 0000950170-24-021570 · ownership.xml · nonDerivative · entry 5 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,577 F7 · shares: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units. F4 · price: Represents the closing price of the common stock of the Issuer on February 23, 2024. Read SEC document |
| February 24, 2024 Filed Feb 28, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 12,787 | $92.80 | $1,186,633.60 |
DisclosureSEC source: 0000950170-24-021570 · ownership.xml · nonDerivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,029 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F4 · price: Represents the closing price of the common stock of the Issuer on February 23, 2024. Read SEC document |
| February 24, 2024 Filed Feb 28, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 25,229 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-021570 · ownership.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 548,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2022 Restricted Stock Units · Derivative | 21,065 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-021570 · ownership.xml · derivative · entry 6 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,066 Underlying: Common Stock · 21,065 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 23, 2024. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 23, 2024. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 23, 2024. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 10,676 | $92.80 | $990,732.80 |
DisclosureSEC source: 0000950170-24-021570 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 523,587 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F4 · price: Represents the closing price of the common stock of the Issuer on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 21,065 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-021570 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 113,362 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017434 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 513,198 F1 · kind: Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2021 to December 31, 2023. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Performance-Based Restricted Stock Units · Derivative | 57,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · derivative · entry 12 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,449 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On February 26, 2020, the reporting person received a target grant of 35,972 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 57,449 units. The performance-based restricted stock units settled on March 6, 2023. F7 · derivative.exercise_date: On February 26, 2020, the reporting person received a target grant of 35,972 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 57,449 units. The performance-based restricted stock units settled on March 6, 2023. F7 · derivative.expiration_date: On February 26, 2020, the reporting person received a target grant of 35,972 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 57,449 units. The performance-based restricted stock units settled on March 6, 2023. F8 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 47,962 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · derivative · entry 11 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,962 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. F6 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. F6 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. F8 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 25,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · derivative · entry 10 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,229 Underlying: Common Stock · 25,229 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F5 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F5 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F8 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2022 February Restricted Stock Units · Derivative | 21,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · derivative · entry 9 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,131 Underlying: Common Stock · 21,065 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F8 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 28,510 | $59.29 | $1,690,357.90 |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · nonDerivative · entry 8 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,836 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 57,449 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · nonDerivative · entry 7 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: On February 26, 2020, the reporting person received a target grant of 35,972 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 57,449 units. The performance-based restricted stock units settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 23,780 | $59.29 | $1,409,916.20 |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · nonDerivative · entry 6 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,897 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 47,962 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · nonDerivative · entry 5 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 12,509 | $59.29 | $741,658.61 |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · nonDerivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,715 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 25,229 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 10,445 | $60.62 | $633,175.90 |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,995 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:32 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 21,065 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017029 · doc4.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:05 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2023 March Restricted Stock Units · Derivative | 109,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015893 · doc4.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,152 Underlying: Common Stock · 109,152 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2019 February Restricted Stock Units · Derivative | 47,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · derivative · entry 9 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,181 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. F5 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. F5 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 47,962 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · derivative · entry 8 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,962 Underlying: Common Stock · 47,962 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,962 shares of common stock, as shown in Table I. The remaining 47,962 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. F4 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,962 shares of common stock, as shown in Table I. The remaining 47,962 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. F4 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,962 shares of common stock, as shown in Table I. The remaining 47,962 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 23,393 | $85.71 | $2,005,014.03 |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · nonDerivative · entry 6 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,375 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 47,181 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · nonDerivative · entry 5 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 23,780 | $85.71 | $2,038,183.80 |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · nonDerivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,587 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 47,962 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,962 shares of common stock, as shown in Table I. The remaining 47,962 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 25,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · derivative · entry 7 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,458 Underlying: Common Stock · 25,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 24, 2021, the reporting person received a grant of 75,686 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 25,228 shares of common stock, as shown in Table I. The remaining 50,458 restricted stock units are shown in Table II, of which 25,229 are scheduled to vest on each of February 24, 2023, and February 24, 2024. F1 · derivative.exercise_date: As previously reported, on February 24, 2021, the reporting person received a grant of 75,686 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 25,228 shares of common stock, as shown in Table I. The remaining 50,458 restricted stock units are shown in Table II, of which 25,229 are scheduled to vest on each of February 24, 2023, and February 24, 2024. F1 · derivative.expiration_date: As previously reported, on February 24, 2021, the reporting person received a grant of 75,686 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 25,228 shares of common stock, as shown in Table I. The remaining 50,458 restricted stock units are shown in Table II, of which 25,229 are scheduled to vest on each of February 24, 2023, and February 24, 2024. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 12,509 | $81.20 | $1,015,730.80 |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,405 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:55 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 25,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-013777 · doc4.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 24, 2021, the reporting person received a grant of 75,686 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 25,228 shares of common stock, as shown in Table I. The remaining 50,458 restricted stock units are shown in Table II, of which 25,229 are scheduled to vest on each of February 24, 2023, and February 24, 2024. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:46 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2022 February Restricted Stock Units · Derivative | 63,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013340 · doc4.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,196 Underlying: Common Stock · 63,196 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 22:04 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2019 January Restricted Stock Units · Derivative | 318,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002440 · doc4.xml · derivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 318,327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on January 31, 2019, the reporting person received a grant of 318,327 time-based restricted stock units, which vested in its entirety on January 6, 2022. F1 · derivative.exercise_date: As previously reported, on January 31, 2019, the reporting person received a grant of 318,327 time-based restricted stock units, which vested in its entirety on January 6, 2022. F1 · derivative.expiration_date: As previously reported, on January 31, 2019, the reporting person received a grant of 318,327 time-based restricted stock units, which vested in its entirety on January 6, 2022. F4 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 22:04 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 155,972 | $77.66 | $12,112,785.52 |
DisclosureSEC source: 0001209191-22-002440 · doc4.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,686 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 22:04 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 318,327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-002440 · doc4.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on January 31, 2019, the reporting person received a grant of 318,327 time-based restricted stock units, which vested in its entirety on January 6, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2021 September Restricted Stock Units · Derivative | 53,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054850 · doc4.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,341 Underlying: Common Stock · 53,341 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in full on August 31, 2025. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in full on August 31, 2025. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in full on August 31, 2025. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:57 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2019 February Restricted Stock Units · Derivative | 47,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016472 · doc4.xml · derivative · entry 6 Sutaria Saumya · CIK 0001760857 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,181 Underlying: Common Stock · 47,181 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. The remaining 47,181 restricted stock units are shown in Table II and are scheduled to vest on February 27, 2022. F4 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. The remaining 47,181 restricted stock units are shown in Table II and are scheduled to vest on February 27, 2022. F4 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. The remaining 47,181 restricted stock units are shown in Table II and are scheduled to vest on February 27, 2022. F5 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:57 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 47,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016472 · doc4.xml · derivative · entry 5 Sutaria Saumya · CIK 0001760857 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,924 Underlying: Common Stock · 47,961 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock, as shown in Table I. The remaining 95,924 restricted stock units are shown in Table II, of which 47,962 are scheduled to vest on each of February 26, 2022 and February 26, 2023. F1 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock, as shown in Table I. The remaining 95,924 restricted stock units are shown in Table II, of which 47,962 are scheduled to vest on each of February 26, 2022 and February 26, 2023. F1 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock, as shown in Table I. The remaining 95,924 restricted stock units are shown in Table II, of which 47,962 are scheduled to vest on each of February 26, 2022 and February 26, 2023. F5 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:57 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 23,393 | $51.02 | $1,193,510.86 |
DisclosureSEC source: 0001209191-21-016472 · doc4.xml · nonDerivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,331 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:57 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 47,181 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-016472 · doc4.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. The remaining 47,181 restricted stock units are shown in Table II and are scheduled to vest on February 27, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:57 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 20,831 | $51.02 | $1,062,797.62 |
DisclosureSEC source: 0001209191-21-016472 · doc4.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,543 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:57 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 47,961 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-016472 · doc4.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock, as shown in Table I. The remaining 95,924 restricted stock units are shown in Table II, of which 47,962 are scheduled to vest on each of February 26, 2022 and February 26, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:47 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2021 February Restricted Stock Units · Derivative | 75,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015028 · doc4.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,686 Underlying: Common Stock · 75,686 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 13:33 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | PurchaseCommon Stock | 20,000 | $17.28 | $345,600.00 |
DisclosureSEC source: 0001209191-20-019448 · doc4.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,413 F1 · shares: The shares were purchased in open market broker transactions. F2 · price: The price is the weighted average purchase price of the aggregate number of shares that were purchased by the reporting person. These shares were purchased in multiple transactions at prices ranging from $16.95 to $17.57. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 27, 2020 Filed Mar 3, 2020 00:13 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2019 February Restricted Stock Units · Derivative | 47,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014803 · doc4.xml · derivative · entry 3 Sutaria Saumya · CIK 0001760857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,362 Underlying: Common Stock · 47,181 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. The remaining 94,362 restricted stock units are shown in Table II, of which 47,181 are scheduled to vest on each of February 27, 2021 and February 27, 2022. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. The remaining 94,362 restricted stock units are shown in Table II, of which 47,181 are scheduled to vest on each of February 27, 2021 and February 27, 2022. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. The remaining 94,362 restricted stock units are shown in Table II, of which 47,181 are scheduled to vest on each of February 27, 2021 and February 27, 2022. F4 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 27, 2020 Filed Mar 3, 2020 00:13 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 17,768 | $26.74 | $475,116.32 |
DisclosureSEC source: 0001209191-20-014803 · doc4.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,413 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 27, 2020 Filed Mar 3, 2020 00:13 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 47,181 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-014803 · doc4.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I. The remaining 94,362 restricted stock units are shown in Table II, of which 47,181 are scheduled to vest on each of February 27, 2021 and February 27, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 23:18 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2020 February Restricted Stock Units · Derivative | 143,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014160 · doc4.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,885 Underlying: Common Stock · 143,885 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:56 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2019 February Restricted Stock Units · Derivative | 141,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015145 · doc4.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,543 Underlying: Common Stock · 141,543 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units will vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units will vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units will vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| January 31, 2019 Filed Feb 5, 2019 00:22 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2019 January Restricted Stock Units · Derivative | 318,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007115 · doc4.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,327 Underlying: Common Stock · 318,327 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units will vest on January 6, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units will vest on January 6, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units will vest on January 6, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.